Method of manufacturing a photovoltaic module comprising at least a first layer and a second layer affixed to each other by means of an encapsulant, said method comprising a lamination step wherein the encapsulant material comprises a silane-modified polyolefin having a melting point below 90° C., pigment particles and an additive comprising a cross-linking catalyst; and wherein in said lamination step heat and pressure are applied to the module, said heat being applied at a temperature between 60° C. and 125° C.

A process of manufacturing a polyolefin drag reducing agent comprises: injecting a catalyst and a drag reducing agent forming component comprising (i) at least one olefin monomer, or (ii) at least one olefin oligomer, or a combination of (i) and (ii) into a temporary container comprising a container material, sealing the temporary container; allowing the drag reducing agent forming component to polymerize in the sealed temporary container to form the polyolefin drag reducing agent; and at least partially dissolving the container material. The container material includes an ethylene vinyl acetate copolymer, an ethylene vinyl alcohol copolymer, a polyvinylpyrrolidone, an ethylene vinylpyrrolidone copolymer, a vinylpyrrolidone vinyl acetate copolymer, a polyvinyl acetate, a polyvinyl alcohol, a polyethylene glycol, a polysaccharide or its derivative, or a combination comprising at least one of the foregoing, provided that when the container material comprises polyvinyl acetate or polyvinyl alcohol, the temporary container is coated or has two or more layers.

A process of manufacturing a polyolefin drag reducing agent comprises: injecting a catalyst and a drag reducing agent forming component comprising (i) at least one olefin monomer, or (ii) at least one olefin oligomer, or a combination of (i) and (ii) into a temporary container comprising a container material, sealing the temporary container; allowing the drag reducing agent forming component to polymerize in the sealed temporary container to form the polyolefin drag reducing agent; and at least partially dissolving the container material. The container material includes an ethylene vinyl acetate copolymer, an ethylene vinyl alcohol copolymer, a polyvinylpyrrolidone, an ethylene vinylpyrrolidone copolymer, a vinylpyrrolidone vinyl acetate copolymer, a polyvinyl acetate, a polyvinyl alcohol, a polyethylene glycol, a polysaccharide or its derivative, or a combination comprising at least one of the foregoing, provided that when the container material comprises polyvinyl acetate or polyvinyl alcohol, the temporary container is coated or has two or more layers.

In one embodiment, a visually clear or transparent and manually flexible medical tube (10) adapted for in vivo transport of an aqueous fluid to a subject comprising an inner layer (3), a middle layer (2) and an outer layer (1), wherein the inner layer (3) comprises a polypropylene, the outer layer (1) comprises a thermoplastic polyurethane or a cyclic olefin copolymer, and the middle layer (2) is selected from one or more of ethylene vinyl acetate copolymers, ethylene acrylate copolymers, ethylene-acrylate maleic anhydride terpolymers, ethylene-acrylate glycidyl methacrylate terpolymers, and maleic anhydride grafted polypropylene.

In one embodiment, a visually clear or transparent and manually flexible medical tube (10) adapted for in vivo transport of an aqueous fluid to a subject comprising an inner layer (3), a middle layer (2) and an outer layer (1), wherein the inner layer (3) comprises a polypropylene, the outer layer (1) comprises a thermoplastic polyurethane or a cyclic olefin copolymer, and the middle layer (2) is selected from one or more of ethylene vinyl acetate copolymers, ethylene acrylate copolymers, ethylene-acrylate maleic anhydride terpolymers, ethylene-acrylate glycidyl methacrylate terpolymers, and maleic anhydride grafted polypropylene.

A primary packaging container for pharmaceuticals is provided. The container includes a hollow body, an opening, and a closure. The hollow body has an opening and is made of a cycloolefin polymer or a cycloolefin copolymer. The closure has a puncture region. The closure closes the opening with the puncturing region at the opening. The puncturing region is configured to allow introduction of a cannula into the hollow body and resealing the hollow body upon withdraw of the cannula. The closure has an elastomer that is connected to the hollow body so as to be not separable in a non-destructive manner.

The present invention pertains to: a non aqueous electrolyte battery binder composition containing a polyamine and a neutralized salt of an -olefin-maleic acid copolymer obtained through copolymerization of an -olefin and maleic acid; and a non aqueous electrolyte battery slurry composition, a non aqueous electrolyte battery negative electrode, and a non aqueous electrolyte battery, etc., using the non aqueous electrolyte battery binder composition.

A primary packaging container for pharmaceuticals is provided. The container includes a hollow body, an opening, and a closure. The hollow body has an opening and is made of a cycloolefin polymer or a cycloolefin copolymer. The closure has a puncture region. The closure closes the opening with the puncturing region at the opening. The puncturing region is configured to allow introduction of a cannula into the hollow body and resealing the hollow body upon withdraw of the cannula. The closure has an elastomer that is connected to the hollow body so as to be not separable in a non-destructive manner.

Provided is a resin composition containing: a cellulose acylate (A); a thermoplastic elastomer (B); and particles (C) of at least one type of organic compound containing two or more nitrogen atoms in a molecule.

Provided is a resin composition containing: a cellulose acylate (A); a thermoplastic elastomer (B); and particles (C) of at least one type of organic compound containing two or more nitrogen atoms in a molecule.